Another drug, ES2, targets FOXO4 conserved region 3 (CR3) but has a significantly lower selectivity than FOXO4-DRI 25
The clinical evidence is still pretty early-stage at this point
TB-500: TB-500 is commonly used to support recovery and tissue repair, thanks to its anti-inflammatory properties
doi: 10.2337/diabetes.53.9.2492 [DOI] [PubMed] [Google Scholar] 93
Quality control considerations for the KLOW formulation include verification of individual peptide purity and identity, assessment of copper content and coordination in the GHK-Cu component, evaluation of peptide stability under storage conditions, and confirmation of biological activity for each component
Figure 1 The median number of outpatient visits within the 180-day period was two (the 1st visit and 2nd visit, as defined in Methods.) Additionally, the interval until the first visit after 180 days was analyzed, and changes in data at these visits were subsequently compared across the dosage groups